Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

IG Compliance Guidance Should Clarify Rx Partial-Fill Policy, NACDS Says

  • News

Executive Summary

The HHS Inspector General should clarify its position on pharmacy billing practices related to partially filled prescriptions, the National Association of Chain Drug Stores said in Aug. 10 comments on the IG's proposed pharmaceutical compliance policy guide.

You may also be interested in...



CVS Integrity Agreement With HHS IG Endorses Partial Rx Fill Policy

CVS' corporate integrity agreement with the HHS Inspector General endorses the drug chain's procedures for handling partially filled prescriptions.

CVS Integrity Agreement With HHS IG Endorses Partial Rx Fill Policy

CVS' corporate integrity agreement with the HHS Inspector General endorses the drug chain's procedures for handling partially filled prescriptions.

Eckerd, Florida Near Settlement On Partial-Fill Rxs; Criminal Plea Entered

Eckerd and Florida Medicaid are negotiating a civil settlement for restitution after the pharmacy chain agreed to $1.7 mil. in federal criminal fines for billing the program for partially filled prescriptions.

Table

View full table

Tags:
Latest Headlines

Global Pharma Guidance Tracker – March 2024

EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials

Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings

China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’

See All
UsernamePublicRestriction

Register

PS038400

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By